Zacks Investment Research on MSN
3 stocks likely to gain from rising HSA contribution & Medicare premium
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...
Abstract: In recent years, pressure sensors have been widely used as crucial technology components in industrial, healthcare, consumer electronics, and automotive safety applications. With the ...
MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
Earlier on November 25, Evercore ISI initiated coverage of DexCom with an In Line rating and $68 price target. While ...
The model, 34, and the comedian, 37, who are parents to daughter Elsie, two, became engaged when he popped the question in ...
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia integration. Read why SENS stock is a buy.
GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...
Abstract: This review paper explores the most common technologies of vector magnetic field sensors. Specifically, the AMR, GMR, TMR, GMI, Hall, Fluxgate, Search Coil and SQUID sensors are considered.
When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experiment: He wore the new biosensor and the previous generation at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results